Food and Drug Administration Center for Drug Evaluation and Research Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting FDA White Oak Campus, Building 31, the Great Room, White Oak Conferen - Oncology Drug Advisory Committee - Document - PDFSEARCH.IO

First Page	Meta Content
	Food and Drug Administration Center for Drug Evaluation and Research Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting FDA White Oak Campus, Building 31, the Great Room, White Oak Conferen Add to Reading List Open Document File Size: 58,63 KB Share Result on Facebook Company MERCK SHARPE AND DOHME / BRISTOL-MYERS SQUIBB CO. / NOVARTIS PHARMACEUTICALS CORPORATION / / Facility Oncologic Drugs Advisory Committee Meeting FDA White Oak Campus / White Oak Conference Center / / IndustryTerm chemical and physical agents / treatment of pediatric cancer / / MedicalCondition tumor / pediatric cancer / pediatric tumor / tumors / neuroblastoma / factor influencing tumor / pediatric cancers / malignant rhabdoid tumors / / Organization Food and Drug Administration Center for Drug Evaluation / Research Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting FDA White Oak Campus / / Person Silver Spring / / SocialTag Neuroblastoma Malignant rhabdoid tumour Atypical teratoid rhabdoid tumor Medicine Oncology Brain tumor

Food and Drug Administration Center for Drug Evaluation and Research Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting FDA White Oak Campus, Building 31, the Great Room, White Oak ConferenAdd to Reading List